A significant number of patients with multiple myeloma continue to relapse and become refractory to currently available therapies, representing one of the largest and most challenging unmet needs in the disease, Ester in t Groen, EMEA Therapeutic Area head, Haematology, at Johnson & Johnson, stated in a news release.1 Making teclistamab monotherapy available to patients as early as second line, where it has the potential to meaningfully improve long-term outcomes and change the course of the disease, could bring new hope to patients and their families. To view or add a comment, sign in 7,047 followers
But that all changed in 2023 when she started using Mounjaro, a drug in the new class of GLP-1 (glucagon-like peptide-1) weight-loss medications
While Nestl is spearheading the food industry response, it isnt the only company tackling the GLP-1 space
Learn more at Managing Nausea While on GLP-1 Medications: Relief Tailored to You You may be a good candidate for a chat-consult with Well Revolution if: If you have severe or worsening symptoms, please seek in-person care immediately
doi: 10.1007/s12630-024-02719-z
